Category Archives: Oncology

Continuing Fallout from the Decision to Overturn Myriad’s Patents

I follow the genetic testing field and have watched the field’s developments since the Myriad decision on patentability of genetic sequences with great interest. One very interesting and very important question is whether the ability to patent naturally occurring genetic … Continue reading






Posted in DTC Genetic Testing, genomics, Oncology, personalized medicine | Comments Off on Continuing Fallout from the Decision to Overturn Myriad’s Patents

Circulating Biomarkers Dundee 2014 a Success!

Circulating Biomarkers Dundee 2014 was a great success! The leadership of Ed Quazi and Elisabetta Fineschi of BioteXcel Ltd. made for a very productive two-day conference with many key leaders in the field from across the UK.  Participants agreed that … Continue reading






Posted in genomics, Oncology, personalized medicine, Uncategorized | Tagged , , , , | Comments Off on Circulating Biomarkers Dundee 2014 a Success!

Where are we with Targeted Cancer Therapeutics?

In a recent project, I received a draft manuscript discussing targeted cancer therapeutics and companion diagnostics in which the writer made this statement: ”CML patients in treatment with Gleevec now have the same life expectancy as people without the disease, … Continue reading

Posted in Oncology, personalized medicine | Tagged , , , , | Comments Off on Where are we with Targeted Cancer Therapeutics?

Time to Rethink Cancer Therapy?

In an earlier post, I wondered a bit about the ultimately causes of cancer.  For the last several decades cancer has been labeled as a genetic disease, an idea which we have chased with great fervor.  Yet, It feels to … Continue reading






Posted in genomics, Oncology, personalized medicine | Tagged , , , , | Comments Off on Time to Rethink Cancer Therapy?

Lessons learned from tumor heterogeneity

My recent blog post, Tumor heterogeneity, revealed…, discussed the New England Journal of Medicine article by Gerlinger and colleagues describing the genetic heterogeneity found both within a patient’s individual tumor nodules and between spatially separate nodules.  There has been a … Continue reading






Posted in genomics, Oncology, personalized medicine, Uncategorized | Tagged , , , , , | Comments Off on Lessons learned from tumor heterogeneity

Tumor Heterogeneity, Revealed…

A very interesting and timely article on tumor heterogeneity was published in the New England Journal of Medicine today.  Gerlinger and colleagues from the UK used next-generation sequencing to look for heterogeneity across various regions of renal tumors and metastases … Continue reading






Posted in genomics, Oncology, personalized medicine, Uncategorized | Tagged , , , | Comments Off on Tumor Heterogeneity, Revealed…

Failure of the Genome?

I recently read an article written by Jonathan Latham in the Guardian (UK) online with the title, “Failure of the Genome” (credit to Genome Web for pointing the post out to their readers).  Following the eye-grabbing headline, the article goes … Continue reading






Posted in Communicating Science, genomics, Oncology | Tagged , , , , | Comments Off on Failure of the Genome?

Recent Developments in DTC Genomic Testing

It’s been relatively quiet on the DTC Genomic Testing front since the turmoil over the FDA’s decision to consider regulating DTC genetic/genomic testing last summer died down.  Nevertheless, there have been a few news items that yielded glimpses of what … Continue reading






Posted in DTC Genetic Testing, genomics, Oncology, personalized medicine | Tagged , , , , , , | Comments Off on Recent Developments in DTC Genomic Testing

Matching Wits with Cancer

An article and a report spurred my thinking about the complexness of the cancer cell phenotype today.  Art Levinson, the long-time CEO and now Chairman of Genentech, wrote an editorial in the 9 April 2010 issue of Science supporting changes … Continue reading






Posted in Oncology | Tagged , , , | Comments Off on Matching Wits with Cancer

Cancer Genes in the News Again

There seems to have been quite a bit of activity in the world of gene-based cancer diagnostics lately.  Just in the last 24 hours some of Myriad Genetics’ BRCA patents were ruled invalid in the United States (http://www.genomicslawreport.com/wp-content/uploads/2010/03/Myriad-SJ-Opinion.pdf) and a … Continue reading






Posted in Oncology | Tagged , , , , | Comments Off on Cancer Genes in the News Again